Fig. 1From: Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillationThe flowchart of the enrollment of study patients. From June 1, 2001, to May 31, 2018, 2944, 5065, 6516, 7336, 3908, 3903, and 4314 AF patients with HbA1c levels of < 5.4%, 5.4%–5.6%, 5.7%–5.9%, 6.0%–6.4%, 6.5%–6.9%, 7.0%–7.9%, and \(\ge\) 8.0%, respectively, were enrolled in the present study. AF = atrial fibrillation; HbA1c = glycated hemoglobin A1cBack to article page